RK Pharma Inc Acquires VGYAAN Pharmaceuticals LLC

22nd Century Group Acquires RX Pharmatech Ltd

January 24, 2023

Food & Beverage

22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.

PAI Pharma Acquires Nivagen Pharmaceuticals

January 8, 2026

Pharmaceuticals

PAI Pharma, an Olympus Partners portfolio company, has acquired Nivagen Pharmaceuticals to add a newly built aseptic sterile-injectable manufacturing facility in Sacramento, California and a pipeline of more than 20 ready-to-use (RTU) injectable products. The add-on expands PAI's sterile injectable capabilities alongside its oral liquid franchise to better serve hospitals and health systems and strengthen U.S. pharmaceutical supply-chain resilience; financial terms were not disclosed.

The Jordan Company Acquires Vyne from Accel-KKR

January 25, 2019

Healthcare Services

The Jordan Company, a middle-market private equity firm, has acquired Vyne, a provider of secure health information exchange and electronic healthcare communication management, from Accel-KKR. The investment will support Vyne's expansion of its technology platforms and services for dental practices, hospitals, health systems and payers across the United States; financial terms were not disclosed.

Kyyba Inc. Acquires Viki Technologies

March 16, 2023

Healthcare Services

Kyyba Inc./Kyyba Tech has agreed to acquire Viki Technologies, a specialist healthcare technology provider based in Farmington Hills, Michigan, for an undisclosed amount. The acquisition expands Kyyba's healthcare capabilities and will integrate Viki's clinical decision support and data-driven tools into Kyyba's broader healthcare solutions platform.

Otsuka Pharmaceutical Acquires Jnana Therapeutics

August 1, 2024

Biotechnology

Otsuka Pharmaceutical Co., Ltd. will acquire clinical-stage biotech Jnana Therapeutics, making it a wholly owned subsidiary via Otsuka America, Inc. The deal values Jnana at $800 million in upfront cash plus up to $325 million in development and regulatory milestones and is intended to add Jnana's RAPID chemoproteomics platform and lead program JNT-517 (a potential oral PKU therapy) to Otsuka's specialty and autoimmune pipeline.

Banyan Software Acquires HealthRx Corporation

June 15, 2021

Software

Banyan Software, a permanent-capital enterprise software acquirer, has purchased HealthRx Corporation, a Fairfax, Virginia–based provider of research workflow, lab safety and occupational health management software (the Nexus platform). The acquisition brings HealthRx's specialized compliance and medical surveillance capabilities into Banyan's portfolio to support continued investment and product growth in the biomedical research and government health markets.